Series B - Bluejay Therapeutics
Investment Firm
Overview
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.
Announced Date
Aug 16, 2022
Funding Type
Series B
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
4
Round Details and Background
Bluejay Therapeutics raised $41000000 on 2022-08-16 in Series B
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Aug 16, 2022 |  Series B - Bluejay Therapeutics | 5 | - | 41.0M |
| May 09, 2024 | Series C - Bluejay Therapeutics | 10 | - | 182.0M |
| Jun 17, 2021 | Venture Round - Bluejay Therapeutics | - | 19.2M |
Recent Activity
There is no recent news or activity for this profile.